Clik here to view.
Research Funding and Economic Growth
Jon Sussex Written by RAND’s Jonathan Grant and OHE’s Jon Sussex, this post originally appeared on 28 November as a Research Fortnight blog post. Increasingly, governments in the UK and throughout...
View ArticleClik here to view.
The Tougher the Better: The Effect of GP Performance Thresholds in Scotland
Yan Feng General Practitioners (GPs) in the NHS are paid based on a mix of factors, including a pay-for-performance element, the Quality and Outcomes Framework (QOF), which was introduced in 2004. QOF...
View ArticleRegister Now: SMEs as a Source of Innovation — OHE Lunchtime Seminar, 4 July
In response to the R&D productivity crisis affecting the pharmaceutical industry, “big pharma” is seeking to source therapeutics from small and medium sized enterprises (SMEs). In this seminar, Dr...
View ArticleClik here to view.
Save the Date: Drug Development in 2022, OHE’s 50th Anniversary Conference
The Economics of Drug Development in 2022 On 8 October, 2012, in celebration of its 50th anniversary, OHE will be holding an important conference to consider what drug development may look like ten...
View ArticleRegister Now: OHE Lunchtime Seminar on Innovation
In response to the R&D productivity crisis affecting the pharmaceutical industry, “big pharma” is seeking to source therapeutics from small and medium sized enterprises (SMEs). In this seminar, Dr...
View ArticleClik here to view.
OHE Study on Pharmaceutical R&D Costs Released
How much it costs to research and develop a successful new medicine has been an important policy issue at least since the 1960s. Cost estimates matter not just because of intellectual curiosity or for...
View ArticleSpotlight on OHE: Value Based Pricing and New Technologies
The OHE has been very active in conceptualising approaches incorporating a broader assessment of the elements of value (often called “value based pricing” or “VBP”), as its publications to date...
View ArticleRealising the Value of Medical Research: Health and Economic Benefits
OHE’s Jon Sussex is spoke today on the value of medical research at the 2013 BioWales conference, one of the UK’s largest life sciences conferences. Celebrating its eleventh year, this conference...
View ArticleClik here to view.
Forecasting the Challenges and Economics of Drug Development in 2022
A new publication from the Office of Health Economics captures the views of thought leaders from around the world about the scientific and economic climate for drug development by 2022. Based on OHE’s...
View ArticleProf Maynard on Ensuring Quality in the NHS: Annual Lecture
Following allegations of seriously substandard care, the Secretary of State for Health in England announced, in June 2010, that a public inquiry into the Mid Staffordshire NHS Foundation Trust would be...
View Article
